Twelve abstracts from the Gene Therapy Program at the University of Pennsylvania were accepted for presentation at the The American Society of Gene & Cell Therapy (ASGCT)'s 25th Annual Meeting, held May 16th-19th 2022 in Washington, D.C. Congratulations to all GTP presenters and their teams!
The Philadelphia Business Journal honored Christina Furia, MS, in its 2022 class of 40 Under 40! Christina is Senior Associate Director of External Manufacturing at GTP. This honor recognizes dynamic business leaders for their achievements and contributions to their companies and the region.
The University of Pennsylvania's Gene Therapy Program (GTP) and The Center for Breakthrough Medicines (CBM) have signed a landmark collaboration agreement to combine Penn's knowledge and expertise in the development of gene therapies with CBM's manufacturing capacity and singular focus on advanced therapies.
